摘要
胃的淋巴网络几乎涉及到上腹部所有的重要血管和脏器,庞大而纷杂,胃癌的淋巴结转移途径也就非常复杂,难以用简单的方法加以概括。日本胃癌研究会以分组标记的方法描述胃的淋巴系统,通过观察不同临床特征胃癌转移阳性淋巴结的分布情况总结其转移规律。为了使研究过程中外科与病理等相关人员按照统一标准记录相应的数据,创建了《日本胃癌处理规约》(以下简称《规约》)。《规约》随着临床研究的深入不断更新,随时纳入最新的研究结果,并将欲解决的突出问题列入其中,以利于进一步研究。所以,《规约》反映着临床对胃癌淋巴结转移规律的最新认识,其修订也与胃癌治疗理念的进步是同步的。经过50余年的艰苦探索,《规约》从无到有,由简到繁,进行了极限性手术的探索以后,渐趋合理,所获得的成熟经验与认识等都成为另一部经典文献《日本胃癌治疗指南》中的主要依据。
The lymphatic network of the stomach involves nearly every important organs and vessels in the epigastrium. As such large and confused network, the lymph node metastasis of stomach is very complicated and difficult to summarize in a simple way. Japanese Gastric Cancer Research used packet marking policy to describe stomach lymphatic system and summarized the laws of LN metastasis by the observation of positive LN distribution area in different clinical manifestations of gastric cancer. In order to ensure that researchers from surgery and pathology record data in accordance with the unified standards during the research, the Japanese Classification of Gastric Carcinoma emerged. With the deepening of the clinical research, the Japanese Classification of Gastric Carcinoma is updated continuously and always incorporated the latest research findings, in the same time it includes outstanding problems needed to be addressed to facilitate further research. So it reflects the latest knowledge of LN metastasis of gastric cancer in clinic and its amendments and the progress of treatment philosophy in gastric cancer are synchronized. After more than 50 years’ painstaking exploration, the Japanese Classification of Gastric Carcinoma has started from scratch and changed from simpleness to complexity. It is more reasonable after limit surgical exploration. Mature experience and knowledge included in the Japanese Classification of Gastric Carcinoma should be the basis of another scripture Japanese Gastric Cancer Treatment Guideline.
出处
《中国实用外科杂志》
CSCD
北大核心
2014年第3期231-234,共4页
Chinese Journal of Practical Surgery
关键词
胃癌
日本胃癌处理规约
gastric cancer
Japanese Classification of Gastric Carcinoma